Publication | Open Access
Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities
13
Citations
28
References
2021
Year
Pre-existing OAC is protective in COVID-19, irrespective of anticoagulation regime during hospital stay and independent of the stage and course of disease.
| Year | Citations | |
|---|---|---|
Page 1
Page 1